GlassScriptPhysician profile
Haroon Khawar
NPI 1659868057
$2,637.76
in general payments reported to CMS, 2019-2025
5 companies · $531 in 2025
The $531 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $341 · 2024: $1,765 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,449 · Food and Beverage: $1,028 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,448.60 |
| Food and Beverage | $1,028.37 |
| Education | $160.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,558.02 | 2023-2025 | Pipeline, Onyx Frontier |
| Stryker Corporation | $654.10 | 2023-2025 | Surpass Evolve, Broadway 8, Trevo |
| Microvention, INC. | $191.74 | 2023-2024 | Web Aneurysm Embolization System, Eric Retrieval Device, Stent |
| Silk Road Medical, INC. | $125.16 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Astrazeneca Pharmaceuticals LP | $108.74 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Khawar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.